ILMN
NASD Illumina, Inc.$271.90 ↑ +0.00 (+0.00%) Trading Up from the previous close of $271.90, $3.79 below the day’s high of $275.69
- YTD change
- +107.30%
- vs 20-day SMA
- +19.70%
- vs 200-day SMA
- +70.70%
Price ranges
Price & Performance
+151.09 (+125.06%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 51.1% away from all-time highs of $555.77
- ILMN is up 107% since the beginning of the year
- ILMN is up 197% over the past 12 months
- ILMN is up 19% over the past 1 month
- 6% of all ILMN investors are betting against ILMN
ILMN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +196.0%.
- Previous minute
- -$0.01
- Last hour
- -$0.02
- Last 5 days
- +13.47%
- vs 8-day SMA
- +8.80%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.